Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkins lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL).
Purity:
>99.0%
CAS Number:
[1875032-68-0]
* VAT and and shipping costs not included. Errors and price changes excepted